Allergy Immunotherapy Market
Allergy Immunotherapy Market - Global Industry Assessment & Forecast
#
Pages:
130
2022
Dec - 2023
VMR-2360
Segments Covered
By
Type Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)
-
By
Allergy Type Allergic Rhinitis, Allergic Asthma, Food Allergy, Atopic Dermatitis, Other Allergy Types
-
By
Distribution Channel Institutional Sales, Retail Sales
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 1.63 Billion |
 Revenue 2030:
|
USD 3.33 Billion |
 Revenue CAGR
(2023 - 2030): |
9.2% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
Europe |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2017 to 2021 |
| 3. | Forecast Data | 2023 to 2030 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
Vantage Market
Research | 10-Jan-2024
FAQ
Frequently Asked Question
What is the global demand for Allergy Immunotherapy in terms of revenue?
-
The global Allergy Immunotherapy valued at USD 1.63 Billion in 2022 and is expected to reach USD 3.33 Billion in 2030 growing at a CAGR of 9.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Merck KGaA (Germany), Jubilant Pharma (Hollister Allergy) (U.S.), Leti Pharma (Spain), Stallergenes Greer (Switzerland), ALK-Abello A/S (Denmark), Allergy Therapeutics (UK), Anergis SA (Switzerland), ASIT Biotech (Belgium), DBV Technologies (France), HAL Allergy Group (Netherlands), Aimmune Therapeutics (U.S.), Arrayit Corporation (U.S.), Biomay AG (Austria).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.2% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Allergy Immunotherapy include
Which region accounted for the largest share in the market?
-
Europe was the leading regional segment of the Allergy Immunotherapy in 2022.
